Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489] - Concepedia

Concepedia

Publication | Open Access

Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]

DOI Full Paper Access

46

Citations

10

References

2005

Year

Sean Curtis, Barry Bockow, Chester Fisher, Joseph Olaleye, Amy Compton, Amy T. Ko, Alise Reicin

BMC Musculoskeletal Disorders

References

	Year	Citations

Page 1